Wendy Gervais, MD
Diagnostic Radiology · Gray, LANPI 1750467007
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $600 and has fallen 72.8% since, to $163 in 2025. Among diagnostic radiology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 116 payments — averaging $20.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$341
- AbbVie$248
- CSL Behring$220
- Amgen$220
- Kyowa Kirin, Inc.$169
- Eisai Inc.$151
- plus $1K from 22 others
What the payments were for
- Speaking & faculty fees$532%
- Food & beverage$2,32598%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 16 | $341 |
| AbbVie | 11 | $248 |
| CSL Behring | 9 | $220 |
| Amgen | 9 | $220 |
| Kyowa Kirin, Inc. | 7 | $169 |
| Eisai Inc. | 7 | $151 |
| EMD Serono, Inc. | 8 | $129 |
| Supernus Pharmaceuticals, Inc. | 9 | $124 |
| Sanofi | 5 | $111 |
| Biogen | 6 | $111 |
| Lundbeck LLC | 3 | $75 |
| ANI Pharmaceuticals, Inc. | 4 | $60 |
| Acorda Therapeutics, Inc | 3 | $53 |
| Neurocrine Biosciences, Inc. | 2 | $41 |
| MDD US Operations, LLC | 2 | $39 |
| Lilly USA, LLC | 2 | $39 |
| Pfizer | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Avanir Pharmaceuticals, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Impel Pharmaceuticals Inc. | 1 | $23 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| Neurelis, Inc. | 1 | $21 |
| Nevro Corp. | 1 | $21 |
| Argenx US, Inc. | 1 | $20 |
| Upsher-smith Laboratories LLC | 1 | $14 |
| Boston Scientific | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,378 in reported general payments places this provider in the 90th percentile of 418 diagnostic radiology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Allopurinol | 11 | $8 |
Paid to pharmacies, not to this prescriber.
Other diagnostic radiology in Gray
- James GrudenNew Orleans$171K
- James RuizBaton Rouge$105K
- Ankit PansaraNew Orleans$28K
- Eric RubinNew Orleans$24K
- Richard TramelNew Orleans$23K
- Dennis KayCovington$19K
- David AllevaBaton Rouge$15K
- John GrezaffiBaton Rouge$12K
- William DawsonMarrero$11K
- Michael DantonioMarrero$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.